ARDELYX, INC. Research and Development Expense
ARDELYX, INC. (ARDX) reported Research and Development Expense of $26.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- ARDELYX, INC. research and development expense for the quarter ending 2026-06-30 was $26.10M, a 66.62% increase year-over-year.
- ARDELYX, INC. research and development expense for the quarter ending 2026-03-31 was $20.19M, a 35.15% increase year-over-year.
- ARDELYX, INC. research and development expense for the quarter ending 2025-12-31 was $22.86M, a 67.25% increase year-over-year.
- ARDELYX, INC. research and development expense for the quarter ending 2025-09-30 was $18.07M, a 18.01% increase year-over-year.
- ARDELYX, INC. research and development expense for fiscal 2025 was $71.53M, a 36.72% increase from fiscal 2024.
- ARDELYX, INC. research and development expense for fiscal 2024 was $52.32M, a 47.22% increase from fiscal 2023.
- ARDELYX, INC. research and development expense for fiscal 2023 was $35.54M, a 0.95% increase from fiscal 2022.
- ARDELYX, INC. research and development expense for fiscal 2022 was $35.20M, a 61.38% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.10M 10-Q · filed 2026-08-06 | $46.29M 10-Q · filed 2026-08-06 | $69.15M derived: sum of 3 quarters · filed 2026-08-06 | $87.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $20.19M 10-Q · filed 2026-04-30 | $43.04M derived: sum of 2 quarters · filed 2026-04-30 | $61.11M derived: sum of 3 quarters · filed 2026-04-30 | $76.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $22.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $40.92M derived: sum of 2 quarters · filed 2026-02-19 | $56.59M derived: sum of 3 quarters · filed 2026-08-06 | $71.53M 10-K · filed 2026-02-19 |
| 2025-09-30 | $18.07M 10-Q · filed 2025-10-30 | $33.73M derived: sum of 2 quarters · filed 2026-08-06 | $48.67M 10-Q · filed 2025-10-30 | $62.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $15.67M 10-Q · filed 2026-08-06 | $30.60M 10-Q · filed 2026-08-06 | $44.27M derived: sum of 3 quarters · filed 2026-08-06 | $59.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $14.94M 10-Q · filed 2026-04-30 | $28.60M derived: sum of 2 quarters · filed 2026-04-30 | $43.91M derived: sum of 3 quarters · filed 2026-04-30 | $56.68M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $13.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $28.98M derived: sum of 2 quarters · filed 2026-02-19 | $41.74M derived: sum of 3 quarters · filed 2026-02-19 | $52.32M 10-K · filed 2026-02-19 |
| 2024-09-30 | $15.31M 10-Q · filed 2025-10-30 | $28.07M derived: sum of 2 quarters · filed 2025-10-30 | $38.65M 10-Q · filed 2025-10-30 | $48.17M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $12.76M 10-Q · filed 2025-08-04 | $23.34M 10-Q · filed 2025-08-04 | $32.87M derived: sum of 3 quarters · filed 2026-02-19 | $41.50M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $10.58M 10-Q · filed 2025-05-01 | $20.10M derived: sum of 2 quarters · filed 2026-02-19 | $28.74M derived: sum of 3 quarters · filed 2026-02-19 | $37.02M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $9.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $18.16M derived: sum of 2 quarters · filed 2026-02-19 | $26.44M derived: sum of 3 quarters · filed 2026-02-19 | $35.54M 10-K · filed 2026-02-19 |
| 2023-09-30 | $8.64M 10-Q · filed 2024-10-31 | $16.92M derived: sum of 2 quarters · filed 2024-10-31 | $26.01M 10-Q · filed 2024-10-31 | $35.15M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $8.28M 10-Q · filed 2024-08-01 | $17.38M 10-Q · filed 2024-08-01 | $26.52M derived: sum of 3 quarters · filed 2025-02-20 | $33.98M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $9.09M 10-Q · filed 2024-05-02 | $18.23M derived: sum of 2 quarters · filed 2025-02-20 | $25.70M derived: sum of 3 quarters · filed 2025-02-20 | $35.44M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $9.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $16.61M derived: sum of 2 quarters · filed 2025-02-20 | $26.35M derived: sum of 3 quarters · filed 2025-02-20 | $35.20M 10-K · filed 2025-02-20 |
| 2022-09-30 | $7.47M 10-Q · filed 2023-10-31 | $17.21M derived: sum of 2 quarters · filed 2023-10-31 | $26.06M 10-Q · filed 2023-10-31 | $47.03M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $9.74M 10-Q · filed 2023-08-02 | $18.59M 10-Q · filed 2023-08-02 | $39.56M derived: sum of 3 quarters · filed 2024-02-22 | $63.26M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $8.85M 10-Q · filed 2023-05-03 | $29.82M derived: sum of 2 quarters · filed 2024-02-22 | $53.51M derived: sum of 3 quarters · filed 2024-02-22 | $79.53M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $20.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $44.66M derived: sum of 2 quarters · filed 2024-02-22 | $70.68M derived: sum of 3 quarters · filed 2024-02-22 | $91.14M 10-K · filed 2024-02-22 |
| 2021-09-30 | $23.70M 10-Q · filed 2022-11-03 | $49.72M derived: sum of 2 quarters · filed 2022-11-03 | $70.17M 10-Q · filed 2022-11-03 | $88.28M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $26.02M 10-Q · filed 2022-08-04 | $46.48M 10-Q · filed 2022-08-04 | $64.58M derived: sum of 3 quarters · filed 2023-03-02 | $76.82M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $20.46M 10-Q · filed 2022-05-05 | $38.56M derived: sum of 2 quarters · filed 2023-03-02 | $50.80M derived: sum of 3 quarters · filed 2023-03-02 | $69.67M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $18.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $30.34M derived: sum of 2 quarters · filed 2023-03-02 | $49.21M derived: sum of 3 quarters · filed 2023-03-02 | $65.05M 10-K · filed 2023-03-02 |
| 2020-09-30 | $12.24M 10-Q · filed 2021-11-12 | $31.10M derived: sum of 2 quarters · filed 2021-11-12 | $46.95M 10-Q · filed 2021-11-12 | $61.19M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $18.86M 10-Q · filed 2021-08-13 | $34.71M 10-Q · filed 2021-08-13 | $48.95M derived: sum of 3 quarters · filed 2022-02-28 | $66.53M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $15.84M 10-Q · filed 2021-05-06 | $30.09M derived: sum of 2 quarters · filed 2022-02-28 | $47.66M derived: sum of 3 quarters · filed 2022-02-28 | $67.14M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $14.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $31.82M derived: sum of 2 quarters · filed 2022-02-28 | $51.30M derived: sum of 3 quarters · filed 2022-02-28 | $71.68M 10-K · filed 2022-02-28 |
| 2019-09-30 | $17.58M 10-Q · filed 2020-11-05 | $37.05M derived: sum of 2 quarters · filed 2020-11-05 | $57.44M 10-Q · filed 2020-11-05 | $79.47M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $19.48M 10-Q · filed 2020-08-06 | $39.86M 10-Q · filed 2020-08-06 | $61.89M derived: sum of 3 quarters · filed 2021-03-08 | $79.83M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $20.38M 10-Q · filed 2020-05-07 | $42.42M derived: sum of 2 quarters · filed 2021-03-08 | $60.36M derived: sum of 3 quarters · filed 2021-03-08 | $76.40M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $22.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $39.98M derived: sum of 2 quarters · filed 2021-03-08 | $56.02M derived: sum of 3 quarters · filed 2021-03-08 | $69.37M 10-K · filed 2021-03-08 |
| 2018-09-30 | $17.94M 10-Q · filed 2019-11-06 | $33.99M derived: sum of 2 quarters · filed 2019-11-06 | $47.34M 10-Q · filed 2019-11-06 | $64.50M derived: sum of 4 quarters · filed 2020-03-06 |
| 2018-06-30 | $16.05M 10-Q · filed 2019-08-09 | $29.40M 10-Q · filed 2019-08-09 | $46.55M derived: sum of 3 quarters · filed 2020-03-06 | $61.92M derived: sum of 4 quarters · filed 2020-03-06 |
| 2018-03-31 | $13.35M 10-Q · filed 2019-05-07 | $30.51M derived: sum of 2 quarters · filed 2020-03-06 | $45.87M derived: sum of 3 quarters · filed 2020-03-06 | $66.45M derived: sum of 4 quarters · filed 2020-03-06 |
| 2017-12-31 | $17.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $32.52M derived: sum of 2 quarters · filed 2020-03-06 | $53.10M derived: sum of 3 quarters · filed 2020-03-06 | $75.48M 10-K · filed 2020-03-06 |
| 2017-09-30 | $15.37M 10-Q · filed 2018-11-07 | $35.94M derived: sum of 2 quarters · filed 2018-11-07 | $58.33M 10-Q · filed 2018-11-07 | $84.53M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $20.57M 10-Q · filed 2018-08-07 | $42.96M 10-Q · filed 2018-08-07 | $69.17M derived: sum of 3 quarters · filed 2019-03-06 | $94.03M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | $22.39M 10-Q · filed 2018-05-08 | $48.60M derived: sum of 2 quarters · filed 2019-03-06 | $73.46M derived: sum of 3 quarters · filed 2019-03-06 | $97.30M derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | $26.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $51.07M derived: sum of 2 quarters · filed 2019-03-06 | $74.91M derived: sum of 3 quarters · filed 2019-03-06 | $94.16M 10-K · filed 2019-03-06 |
| 2016-09-30 | $24.86M 10-Q · filed 2017-11-07 | $48.70M derived: sum of 2 quarters · filed 2017-11-07 | $67.95M 10-Q · filed 2017-11-07 | $80.73M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $23.84M 10-Q · filed 2017-08-09 | $43.09M 10-Q · filed 2017-08-09 | $55.87M derived: sum of 3 quarters · filed 2018-03-14 | $70.58M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $19.25M 10-Q · filed 2017-05-05 | $32.03M derived: sum of 2 quarters · filed 2018-03-14 | $46.74M derived: sum of 3 quarters · filed 2018-03-14 | $52.94M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $12.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $27.49M derived: sum of 2 quarters · filed 2018-03-14 | $33.69M derived: sum of 3 quarters · filed 2018-03-14 | $39.88M 10-K · filed 2018-03-14 |
| 2015-09-30 | $14.71M 10-Q · filed 2016-11-07 | $20.90M derived: sum of 2 quarters · filed 2016-11-07 | $27.10M 10-Q · filed 2016-11-07 | $34.49M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $6.20M 10-Q · filed 2016-08-08 | $12.40M 10-Q · filed 2016-08-08 | $19.78M derived: sum of 3 quarters · filed 2017-02-17 | $25.48M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $6.20M 10-Q · filed 2016-05-09 | $13.58M derived: sum of 2 quarters · filed 2017-02-17 | $19.28M derived: sum of 3 quarters · filed 2017-02-17 | $24.46M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $7.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $13.08M derived: sum of 2 quarters · filed 2017-02-17 | $18.26M derived: sum of 3 quarters · filed 2017-02-17 | $25.90M 10-K · filed 2017-02-17 |
| 2014-09-30 | $5.69M 10-Q · filed 2015-11-12 | $10.88M derived: sum of 2 quarters · filed 2015-11-12 | $18.51M 10-Q · filed 2015-11-12 | $26.85M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-06-30 | $5.18M 10-Q · filed 2015-08-12 | $12.82M 10-Q · filed 2015-08-12 | $21.16M derived: sum of 3 quarters · filed 2016-03-04 | $27.74M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-03-31 | $7.64M 10-Q · filed 2015-05-12 | $15.97M derived: sum of 2 quarters · filed 2016-03-04 | $22.56M derived: sum of 3 quarters · filed 2016-03-04 | $29.79M derived: sum of 4 quarters · filed 2016-03-04 |
| 2013-12-31 | $8.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | $14.92M derived: sum of 2 quarters · filed 2016-03-04 | $22.15M derived: sum of 3 quarters · filed 2016-03-04 | $28.09M 10-K · filed 2016-03-04 |
| 2013-09-30 | $6.58M 10-Q · filed 2014-11-07 | $13.82M derived: sum of 2 quarters · filed 2014-11-07 | $19.76M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $7.23M 10-Q · filed 2014-08-08 | $13.17M 10-Q · filed 2014-08-08 | ||
| 2012-12-31 | $10.18M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |